Impact of Precision Medicine in Oncology Immuno-oncology

被引：0

作者：

Buchbinder, Elizabeth I. ^{[1
,2
,3
,5
]}

Hodi, F. Stephen ^{[1
,2
,3
,4
]}

机构：

[1] Dana Farber Canc Inst, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

[4] Dana Farber Canc Inst, Ctr Immuno Oncol, Boston, MA USA

[5] 450 Brookline Ave, Boston, MA 02215 USA

来源：

CANCER JOURNAL | 2023年 / 29卷 / 01期

关键词：

CAR-T cell; immune checkpoint inhibition; immunotherapy; cellular therapy; cytokine; TIL therapy; INTERLEUKIN-2 HD IL-2; RENAL-CELL CARCINOMA; METASTATIC MELANOMA; T-CELLS; PD-1; CTLA-4; THERAPY; IMMUNOTHERAPY; IPILIMUMAB; BLOCKADE;

D O I：

10.1097/PPO.0000000000000641

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.

引用

页码：15 / 19

页数：5

共 50 条

[31] Biotech and Breakthroughs in Immuno-Oncology [J].

Bockman, Jeffrey M. .

UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) :511-521

[32] Multiplex imaging in immuno-oncology [J].

Zhao, Chen ;

Germain, Ronald N. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)

[33] Immuno-Oncology for Gynecologic Malignancies [J].

How, Jeffrey A. ;

Patel, Ami ;

Jazaeri, Amir A. .

IMMUNOTHERAPY, 4TH EDITION, 2021, 1342 :193-232

[34] Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology [J].

Manne, Ashish ;

Woods, Edward ;

Tsung, Allan ;

Mittra, Arjun .

FRONTIERS IN ONCOLOGY, 2021, 11

[35] A mathematical model of viral oncology as an immuno-oncology instigator [J].

Cassidy, Tyler ;

Humphries, Antony R. .

MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA, 2020, 37 (01) :117-151

[36] Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo [J].

Olofsson, Gitte Holmen ;

Jensen, Agnete Witness Praest ;

Idorn, Manja ;

Straten, Per Thor .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11)

[37] Postablation Immune Microenvironment: Synergy between Interventional Oncology and Immuno-oncology [J].

Kim, DaeHee ;

Erinjeri, Joseph P. .

SEMINARS IN INTERVENTIONAL RADIOLOGY, 2019, 36 (04) :334-342

[38] Immuno-oncology - An Overview [J].

Kobold, Sebastian ;

Krackhardt, Angela ;

Schloesser, Hans ;

Wolf, Dominik .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (14) :1006-1013

[39] The Microbiome in Immuno-oncology [J].

Toker, Joseph ;

Arora, Reetakshi ;

Wargo, Jennifer A. .

IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 :325-334

[40] Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms [J].

Song, Wantong ;

Das, Manisit ;

Chen, Xuesi .

TRENDS IN CANCER, 2020, 6 (04) :288-298

← 1 2 3 4 5 →